Search Results

1. • GuruFocus.com · via Yahoo Finance

     Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight

     1 year ago ·

     Exact Sciences Corp showcases robust revenue growth amidst operational challenges. Innovative cancer...

2. • GuruFocus.com · via Yahoo Finance

     Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue...

     1 year ago ·

     Exact Sciences Corp (EXAS) reports robust financial performance with a 52% increase in adjusted...

3. • Insider Monkey · via Yahoo Finance

     Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement

     1 month ago ·

     Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 20...

4. • Insider Monkey · via Yahoo Finance

     Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder...

     7 days ago ·

     Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after...

5. • GuruFocus.com · via Yahoo Finance

     FMR LLC Bolsters Stake in Exact Sciences Corp

     1 year ago ·

     Overview of the Recent Transaction On September 30, 2024, FMR LLC (Trades, Portfolio), a prominent investment firm, significantly increased its...

6. • Insider Monkey · via Yahoo Finance

     Should You Invest in Exact Sciences Corp. (EXAS)?

     12 months ago ·

     Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 investor letter. A copy of the l...

7. • Benzinga · via Yahoo Finance

     Exact Sciences Dip A Chance To Buy As Freenome Deal Fortifies Future: Analyst

     7 months ago ·

     Exact Sciences Corp. (NYSE:EXAS) on Thursday reported a second-quarter 2025 EPS loss of 1 cent, up...

8. • Insider Monkey · via Yahoo Finance

     Exact Sciences (EXAS) Climbs to 2-Year High on Abbot Merger Reports

     3 months ago ·

     We recently published 10 Stocks Beating Wall Street at its Own Game. Exact Sciences Corp....

9. • Benzinga · via Yahoo Finance

     Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual...

     1 year ago ·

     On Tuesday, Exact Sciences Corp. (NASDAQ:EXAS) reported a third-quarter EPS loss of $0.21, compared...

10. • GuruFocus.com · via Yahoo Finance

      Exact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net...

      2 years ago ·

      Revenue: Reported $638 million, a 6% increase year-over-year, falling short of the estimated $700.15 million. Net Loss: Widened to $110 million from $74 million year-over-year, significantly ...